Novartis ribociclib Phase III NATALEE trial meets primary endpoint at interim analysis to benefit patients with early breast cancer

undefined

Related Keywords

California ,United States ,Philippine ,Benguet ,Philippines ,Joel Chong ,Shreeram Aradhye ,Rosariov Pitargue ,Dennisj Slamon ,Philippine Society Of Medical Oncology ,Data Monitoring Committee ,Los Angeles Jonsson Comprehensive Cancer Center ,Novartis ,Novartis Healthcare Philippines Inc ,Global Drug Development ,Clinical Translational Research ,University Of California ,Translational Research In Oncology ,Independent Data Monitoring Committee ,Translational Research ,Executive Director ,Chief Medical Officer ,Philippine Society ,Medical Oncology ,Country President ,Novartis Healthcare Philippines ,